Delivery Order SPE2DB24D1205-SPE2DB25FCYUU
- Not listed
- The Defense Logistics Agency awarded a $33,272.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-unit packaging) with a completion date of July 22, 2025. This non-set-aside competitive award was issued on July 21, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's ongoing pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.61 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,954.30 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a $24,347.36 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. DESCOVY is an antiretroviral medication...
- The Defense Logistics Agency awarded a delivery order valued at $5,795.72 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV treatment medication combining emtricitabine and tenofovir alafenamide,...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.52 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,208.36 to AmerisourceBergen Drug Corp for 30 tablets of DESCOVY 200-25 mg, an antiretroviral medication used in HIV treatment and prevention. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $14,991.82 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCYUUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $19,179.38. This non-competitive delivery order is expected to be completed by July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV prevention and treatment medication, reflecting the federal government's ongoing pharmaceutical procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad range of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency and other federal healthcare programs globally. The company was selected as a prime vendor through competitive processes, demonstrating its capability to meet federal medical procurement requirements and fulfill critical pharmaceutical supply needs for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 7/22/25 |